Listening to fluoxetine: a hot message from the FLAME trial of poststroke motor recovery

International Journal of Stroke

Volumn 6, Issue 4, 2011, Pages 315-316

  Cramer, Steven C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Clinical trial; Plasticity; Recovery; Selective serotonin reuptake inhibitors; Stroke

Indexed keywords

FLUOXETINE; PLACEBO;

ARTICLE; BRAIN ISCHEMIA; DEPRESSION; FUGL MEYER SCORE; GENERAL CONDITION IMPROVEMENT; HUMAN; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; OUTCOME ASSESSMENT; POSTSTROKE MOTOR RECOVERY; PRIORITY JOURNAL; RANKIN SCALE; RATING SCALE;

DOUBLE-BLIND METHOD; FLUOXETINE; HUMANS; MOTOR ACTIVITY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECOVERY OF FUNCTION; SEROTONIN UPTAKE INHIBITORS; STROKE;

EID: 79960208831     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/j.1747-4949.2011.00618.x     Document Type: Article

References (10)

1. Cramer SC. Repairing the human brain after stroke. II. Restorative therapies. Ann Neurol 2008; 63:549-60.
2. Miyai I, Reding R. Effects of antidepressants on functional recovery following stroke. J Neuro Rehab 1998; 12:5-13.
3. Dam M, Tonin P, De Boni A et al. Effects of fluoxetine and maprotiline on functional recovery in poststroke hemiplegic patients undergoing rehabilitation therapy. Stroke 1996; 27:1211-4.
4. Pariente J, Loubinoux I, Carel C et al. Fluoxetine modulates motor performance and cerebral activation of patients recovering from stroke. Ann Neurol 2001; 50:718-29.
5. Robinson RG, Jorge RE, Moser DJ et al. Escitalopram and problem-solving therapy for prevention of poststroke depression: a randomized controlled trial. JAMA 2008; 299:2391-400.
6. Jorge RE, Acion L, Moser D, Adams HP Jr, Robinson RG. Escitalopram and enhancement of cognitive recovery following stroke. Arch Gen Psychiatry 2010; 67:187-96.
7. Chollet F, Tardy J, Albucher JF et al. Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial. Lancet Neurol 2011; 10:123-30.
8. Cramer SC, Koroshetz WJ, Finklestein SP. The case for modality-specific outcome measures in clinical trials of stroke recovery-promoting agents. Stroke 2007; 38:1393-5.
9. Cramer SC. Issues in clinical trial methodology for brain repair after stroke in Cramer SC, Nudo RJ (eds): Brain Repair After Stroke. Cambridge, UK: Cambridge University Press, 2010: 173-82.
10. Cramer S, Sur M, Dobkin B et al. Harnessing neuroplasticity for clinical applications. Brain 2011; 134:1591-1609.